Invention Application
- Patent Title: BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS
-
Application No.: US16824290Application Date: 2020-03-19
-
Publication No.: US20200216406A1Publication Date: 2020-07-09
- Inventor: Jay Copeland Strum
- Applicant: G1 Therapeutics, Inc.
- Applicant Address: US NC Research Triangle Park
- Assignee: G1 Therapeutics, Inc.
- Current Assignee: G1 Therapeutics, Inc.
- Current Assignee Address: US NC Research Triangle Park
- Main IPC: C07D333/64
- IPC: C07D333/64 ; A61K31/55 ; A61P35/00 ; A61K31/397 ; A61K31/4025 ; A61K31/499 ; A61K31/4535 ; C07D409/12 ; A61K31/381
Abstract:
This invention is a benzothiophene estrogen receptor modulator or its pharmaceutically acceptable salt or a pharmaceutically acceptable composition thereof to treat an estrogen-related medical disorder.
Public/Granted literature
- US10981887B2 Benzothiophene estrogen receptor modulators Public/Granted day:2021-04-20
Information query
